NASDAQ:MESO

Mesoblast Stock Insider Trading

etoro logo Buy MESO
*Your capital is at risk
$14.17
-0.380 (-2.61%)
At Close: Jul 31, 2026

Mesoblast Stock Insider Power

Based on the 79 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 32.04M and sold 0 MESO shares in the last 79 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 79 transactions)
100.00
Buy 32.04M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 09, 2026
Buy
Ordinary Shares
P-Purchase
George Gregory
Director 10 000
Value: $141.0K
Apr 04, 2026
Buy
Ordinary Shares
P-Purchase
George Gregory
Director 4 000 000
Value: $5.68M
Mar 18, 2026
Buy
Option (right to buy)
Cobley Lynette Elizabeth
Director
Director 200 000
Value: $344.0K
Mar 18, 2026
Buy
Ordinary Shares
Cobley Lynette Elizabeth
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Cobley Lynette Elizabeth
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Itescu Silviu
CEO And Managing Director
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Burns William Murray
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Itescu Silviu
CEO And Managing Director
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Itescu Silviu
CEO And Managing Director
CEO / President 0
Value: $0
Mar 18, 2026
Buy
Option (right to buy)
Itescu Silviu
CEO And Managing Director
CEO / President 673 333
Value: $976.3K
Mar 18, 2026
Buy
Option (right to buy)
Itescu Silviu
CEO And Managing Director
CEO / President 1 950 000
Value: $4.80M
Mar 18, 2026
Buy
Option (right to buy)
Itescu Silviu
CEO And Managing Director
CEO / President 930 000
Value: $1.63M
Mar 18, 2026
Buy
Option (right to buy)
Itescu Silviu
CEO And Managing Director
CEO / President 1 395 000
Value: $1.41M
Mar 18, 2026
Buy
Option (right to buy)
Itescu Silviu
CEO And Managing Director
CEO / President 806 666
Value: $282.3K
Mar 18, 2026
Buy
Option (right to buy)
Itescu Silviu
CEO And Managing Director
CEO / President 2 072 000
Value: $2.01M
Mar 18, 2026
Buy
Ordinary Shares
George Gregory
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
George Gregory
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
George Gregory
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
George Gregory
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
George Gregory
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
George Gregory
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Option (right to buy)
Rose Eric Allen
Chief Medical Officer,director
Officer 820 000
Value: $2.02M
Mar 18, 2026
Buy
Option (right to buy)
Rose Eric Allen
Chief Medical Officer,director
Officer 630 666
Value: $611.7K
Mar 18, 2026
Buy
Option (right to buy)
Rose Eric Allen
Chief Medical Officer,director
Officer 592 000
Value: $207.2K
Mar 18, 2026
Buy
Ordinary Shares
Rose Eric Allen
Chief Medical Officer,director
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MESOBLAST LTD
Mesoblast
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE